Detalles de la búsqueda
1.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
PLoS Med
; 19(1): e1003865, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015777
2.
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Ann Intern Med
; 174(5): 585-594, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587687
3.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
PLoS Med
; 18(10): e1003813, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714820
4.
Mutations in the intellectual disability gene Ube2a cause neuronal dysfunction and impair parkin-dependent mitophagy.
Mol Cell
; 50(6): 831-43, 2013 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685073
5.
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
J Infect Dis
; 215(1): 24-33, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694633
6.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Lancet Glob Health
; 11(11): e1743-e1752, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858585
7.
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
BMJ Open
; 12(3): e055596, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260458
8.
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.
Trials
; 23(1): 513, 2022 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35725488
9.
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
NPJ Vaccines
; 7(1): 156, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450746
10.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Lancet Infect Dis
; 22(1): 110-122, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529962
11.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
Lancet Infect Dis
; 22(1): 97-109, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529963
12.
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen.
NPJ Vaccines
; 6(1): 157, 2021 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930928
13.
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
Vaccine
; 39(22): 3081-3101, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676782
14.
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
Lancet Infect Dis
; 21(4): 493-506, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217361
15.
Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.
Kidney Int
; 77(3): 247-55, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19940840
16.
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.
BMC Infect Dis
; 10: 357, 2010 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21171982
17.
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults.
Hum Vaccin
; 6(7): 578-84, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20523113
18.
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
NPJ Vaccines
; 5(1): 112, 2020 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33335092
19.
Axonal injury and regeneration in the adult brain of Drosophila.
J Neurosci
; 28(23): 6010-21, 2008 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-18524906
20.
Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.
J Med Virol
; 81(10): 1710-5, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19697416